🇺🇸 Low dose ASA in United States

58 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 58

Most-reported reactions

1. Nausea — 10 reports (17.24%)
2. Dizziness — 7 reports (12.07%)
3. Fatigue — 7 reports (12.07%)
4. Flushing — 7 reports (12.07%)
5. Dyspnoea — 5 reports (8.62%)
6. Insomnia — 5 reports (8.62%)
7. Vomiting — 5 reports (8.62%)
8. Anxiety — 4 reports (6.9%)
9. Asthenia — 4 reports (6.9%)
10. Decreased Appetite — 4 reports (6.9%)

Source database →

Frequently asked questions

Is Low dose ASA approved in United States?

Low dose ASA does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Low dose ASA in United States?

University of Pennsylvania is the originator. The local marketing authorisation holder may differ — check the official source linked above.